Kodiak Sciences (KOD) Cash from Operations (2017 - 2026)
Kodiak Sciences (KOD) reported Cash from Operations of 40009000.0 for Q1 2026, down 37.6% on a YoY basis from 64113623.2 in Q1 2025, and down 1.6% quarter-over-quarter from 39378000.0 in Q4 2025.
Kodiak Sciences (KOD) Cash from Operations (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Cash from Operations for 10 years, with the latest figure at 40009000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 37.6% year-over-year to 40009000.0; the trailing twelve-month figure through Mar 2026 stood at 146940000.0 (down 37.61% YoY), and the FY2025 full-year result was 136008000.0, down 15.95% from the prior year.
- Cash from Operations for Q1 2026 stood at 40009000.0, down from 39378000.0 in the prior quarter.
- The five-year high for Cash from Operations was 21149000.0 in Q3 2024, with the low at 55137000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 38470588.24 across 5 years, with a median of 39378000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 41.51% — and 2025, when it plunged 55.23%.
- Kodiak Sciences' Cash from Operations stood at 55116000.0 in 2022, then jumped by 41.51% to 32239000.0 in 2023, then increased by 6.79% to 30051000.0 in 2024, then sank by 31.04% to 39378000.0 in 2025, then fell by 1.6% to 40009000.0 in 2026.
- The last three Cash from Operations figures came in at 40009000.0 (Q1 2026), 39378000.0 (Q4 2025), and 32830000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -40.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.01 Mn |
| Mar 31, 2026 | -40.01 Mn |
| Dec 31, 2025 | -39.38 Mn |
| Dec 31, 2025 | -39.38 Mn |
| Sep 30, 2025 | -32.83 Mn |
| Sep 30, 2025 | -32.83 Mn |
| Jun 30, 2025 | -34.72 Mn |
| Jun 30, 2025 | -34.72 Mn |
| Mar 31, 2025 | -29.08 Mn |
| Mar 31, 2025 | -29.08 Mn |
| Dec 31, 2024 | -30.05 Mn |
| Dec 31, 2024 | -30.05 Mn |
| Sep 30, 2024 | -21.15 Mn |
| Sep 30, 2024 | -21.15 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -39.60 Mn |
| Mar 31, 2024 | -39.60 Mn |
| Dec 31, 2023 | -32.24 Mn |
| Dec 31, 2023 | -32.24 Mn |